Published in Nephrol Dial Transplant on June 10, 2010
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21
Changes in immune cell frequencies after cyclophosphamide or mycophenolate mofetil treatments in patients with systemic lupus erythematosus. Clin Rheumatol (2012) 0.80
Adverse event burden, resource use, and costs associated with immunosuppressant medications for the treatment of systemic lupus erythematosus: a systematic literature review. Int J Rheumatol (2013) 0.80
Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study. Arthritis Res Ther (2010) 0.78
Treatment of young patients with lupus nephritis using calcineurin inhibitors. World J Nephrol (2012) 0.78
TAC-TIC use of tacrolimus-based regimens in lupus nephritis. Lupus Sci Med (2016) 0.75
Successful treatment with mycophenolate mofetil and tacrolimus in juvenile severe lupus nephritis. Case Rep Pediatr (2015) 0.75
[Established medications : new areas of application]. Z Rheumatol (2013) 0.75
Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Arthritis Res Ther (2009) 1.52
Livedo racemosa as a marker of increased risk of recurrent thrombosis in patients with negative anti-phospholipid antibodies. Med Clin (Barc) (2009) 1.39
[Neuropsyquiatric manifestations in systemic lupus erythematosus]. Med Clin (Barc) (2009) 1.39
Implication of human endogenous retroviruses in the development of autoimmune diseases. Int Rev Immunol (2010) 1.18
DNase 1 and systemic lupus erythematosus. Autoimmun Rev (2008) 1.12
Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus. Arthritis Res Ther (2012) 1.09
Molecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity. Rev Med Virol (2009) 1.08
Antihistone and anti-double-stranded deoxyribonucleic acid antibodies are associated with renal disease in systemic lupus erythematosus. Am J Med (2004) 1.05
DNA methylation and systemic lupus erythematosus. Ann N Y Acad Sci (2007) 1.00
Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology (2008) 0.97
Further evidence of subphenotype association with systemic lupus erythematosus susceptibility loci: a European cases only study. PLoS One (2012) 0.90
Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: a case-control study. Arthritis Res Ther (2012) 0.89
Transcript overexpression of the MBD2 and MBD4 genes in CD4+ T cells from systemic lupus erythematosus patients. J Leukoc Biol (2007) 0.89
Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus. J Rheumatol (2009) 0.86
The complex immunogenetic basis of systemic lupus erythematosus. Autoimmun Rev (2008) 0.86
Association of systemic lupus erythematosus clinical features with European population genetic substructure. PLoS One (2011) 0.85
DNase1 activity in systemic lupus erythematosus patients with and without nephropathy. Rheumatol Int (2009) 0.83
Genetic risk factors of thrombosis in the antiphospholipid syndrome. Br J Haematol (2009) 0.82
Mutations of activin-receptor-like kinase 1 (ALK-1) are not found in patients with pulmonary hypertension and underlying connective tissue disease. Clin Rheumatol (2006) 0.79
Associations between the expression of epigenetically regulated genes and the expression of DNMTs and MBDs in systemic lupus erythematosus. PLoS One (2012) 0.79
Xenotropic murine leukemia virus-related virus (XMRV) in patients with systemic lupus erythematosus. J Clin Immunol (2011) 0.79
DNASE I mutation and systemic lupus erythematosus in a Spanish population: comment on the article by Tew et al. Arthritis Rheum (2002) 0.79
Clinical and serological findings associated with the expression of ITGAL, PRF1, and CD70 in systemic lupus erythematosus. Clin Exp Rheumatol (2013) 0.78
Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study. J Rheumatol (2009) 0.77
[Atherosclerosis and anti-oxidized low density lipoprotein antibodies in an elderly population]. Med Clin (Barc) (2002) 0.76
Systemic lupus erythematosus as a first presentation of common variable immunodeficiency associated with infrequent mannose-binding lectin gene polymorphisms. Rheumatol Int (2009) 0.76
Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus. Arthritis Res Ther (2014) 0.75
Enhanced transcript levels of CD48 in CD4⁺ T cells from systemic lupus erythematosus patients. Immunobiology (2011) 0.75
[Systemic lupus erythematosus and accelerated atheromatosis]. Med Clin (Barc) (2004) 0.75